Becoming Strategic: The Evolution of the Flinn Foundation (2009): According to Martin Shultz, vice president of Pinnacle West Capital, the state’s largest utility, Flinn’s strategic and collaborative effort to build Arizona’s bioscience infrastructure has changed the landscape. “There was little here before,” he says, “and now we have in Arizona many, many examples of new biomedical discoveries – many of which have been FDA approved and are in the market.”

Flinn’s journey began with a belief that the Foundation could play a distinctive role in improving healthcare. According to Flinn’s president and CEO John W. Murphy, “One of the reasons for investing in bioscience is that you want to be able to apply laboratory discoveries to patients more efficiently and effectively.” To fulfill that vision, Flinn tightened its focus, defined specific goals, and created metrics to measure its progress along the way.

Download the full report

View all of CEP's publications